Wockhardt jumps on US FDA nod for generic drug
Wockhardt and Sun Pharmaceutical have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug.
Pharma
Bharat Biotech
Bharat Biotech International, a leading manufacturer of vaccines and biotherapeutics announced its Anti-Staphylococcal Molecule
Pharma stocks in the pink of health
Shares of fourteen drug makers rose by 0.99% to 6.16% on reports global pharma firms are scouting for acquiring Indian drug makers, as generic penetration in the developed market is expected to increase in the coming years.
Pharma industry steps up recruitment 5 times
At a time when global multinational drug makers are slashing their workforces to reduce costs, their Indian counterparts are on a hiring spree.
Patent expiry to open huge opportunity
Patent expiry will be a major avenue of growth for the Indian pharmaceutical industry as products worth $235 billion are going off patent within horizon of five years (from 2009 to 2014).
Six new pharma research centers
Finally,the government has fulfilled the demand of pharmaceutical industry to meet its long-standing demand of trained manpower by giving in principle approval for setting up of six National Institutes of Pharmaceutical Education and Research (NIPER)
Funding by Pharmaceutical industry to help fight Meth labs in Missouri, Kansas
New laws in Kansas and Missouri, prescribe a methamphetamine cook shouldn
India to see Pentavalent vaccine
Introduction of pentavalent vaccine in the National Immunisation Programme, was kept pending for quite a while, is likely to take off soon.
Arcadia Pharmacy Software Business sold for $2.2m
Retail pharmacy management software business was sold by Arcadia for $2.2 million, cash, to an undisclosed pharmacy benefits management company.
IT 2010 awards for pharmacy
FDBE with The Guild of Healthcare Pharmacists (GHP) and the UK Clinical Pharmacy Association (UKCPA), are pleased to announce the 2010 FDBE/GHP/UKCPA Information Technology Award.
Vaccine plant in Singapore for pneumonia by GSK
On Tuesday, drug maker GlaxoSmithKline (GSK), established a US $600 million plant in Singapore that is stated to begin producing anti-pneumonia vaccine in 2011.
Inadequate medical isotope reach crisis fractions
Lack of adequate isotopes will be an important subject of discussion for the experts convening at the Society of Nuclear Medicine (SNM) meeting in Toronto on the coming weekend.
Cadila expects Rs 100-cr revenue from Policap
Ahmedabad-based Cadila Pharmaceuticals on Saturday said it is expecting a revenue of INR 100 crore from the sale of its patented combination drug, Policap, which it expects to launch by the middle of next month.
